Skip to main content
C

CanBas Co.,Ltd. — Investor Relations & Filings

Ticker · 4575 ISIN · JP3244570002 T Professional, scientific and technical activities
Filings indexed 65 across all filing types
Latest filing 2025-09-29 Audit Report / Informat…
Country JP Japan
Listing T 4575

About CanBas Co.,Ltd.

https://www.canbas.co.jp/

CanBas is a clinical-stage biopharmaceutical company dedicated to the research and development of novel therapeutics for cancer patients. The company focuses on drug discovery in the field of oncology, including immuno-oncology and treatments targeting the cell cycle. Its pipeline includes CBP501, a calmodulin-modulating peptide that has undergone Phase II clinical trials. CanBas leverages proprietary screening systems and core technologies to develop innovative anti-cancer agents, with a focus on creating treatments with potentially fewer side effects.

Recent filings

Filing Released Lang Actions
確認書
Audit Report / Information Classification · 1% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under Article 24-4-2 of the Financial Instruments and Exchange Act of Japan. This is a mandatory regulatory filing that accompanies the Annual Securities Report (Yukashoken Hokokusho) to confirm the accuracy of the financial statements. Since it is a specific regulatory filing required by law and does not fit into the other categories like 10-K or IR, it is classified as a Regulatory Filing (RNS). FY 2025
2025-09-29 Japanese
有価証券報告書-第26期(2024/07/01-2025/06/30)
Annual Report Classification · 1% confidence The document is a 'Yuka Shoken Hokokusho' (Annual Securities Report) for the company 'CanBas Co., Ltd.' for the fiscal year ending June 30, 2025. It contains detailed financial statements, business descriptions, and corporate information as required by the Financial Instruments and Exchange Act of Japan. This document is the primary annual financial filing for a Japanese public company, which corresponds to the '10-K' category in the provided schema. FY 2025
2025-09-29 Japanese
確認書
Report Publication Announcement Classification · 1% confidence The document text contains the title "第2四半期報告書" (Second Quarter Report) and explicitly mentions the period covered: "第26期中間期(自 2024年7月1日 至 2024年12月31日)" (26th Fiscal Year Second Quarter Period (From July 1, 2024, to December 31, 2024)). It also includes confirmation statements regarding the appropriateness of the half-year report's contents, filed with the Kanto Local Finance Bureau. This structure and content strongly indicate a comprehensive financial report covering a period shorter than a year, which corresponds to the Interim / Quarterly Report definition. Classification: IR (Interim / Quarterly Report).
2025-02-13 Japanese
半期報告書-第26期(2024/07/01-2025/06/30)
Interim / Quarterly Report Classification · 1% confidence The document is a '半期報告書' (Semi-Annual Report) for the company '株式会社キャンバス' (CanBas Co., Ltd.) covering the period from July 1, 2024, to December 31, 2024. It contains detailed financial statements, management analysis, and audit information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2025
2025-02-13 Japanese
臨時報告書
AGM Information Classification · 1% confidence The document is titled "臨時報告書" (Extraordinary Report/Timely Disclosure Report) and explicitly states in Section 1 that it is being submitted because resolutions were passed at the Annual General Meeting (AGM) held on September 27, 2024, in accordance with Japanese financial regulations (FSA Cabinet Office Ordinance Article 19, Paragraph 2, Item 9-2). Section 2 details the resolutions, which concern the election of Directors and Audit Committee Members. This document reports the results of the shareholder vote. Since the document reports the official results of voting at a general meeting, the most appropriate classification is Declaration of Voting Results & Voting Rights Announcements (DVA). It is not the AGM presentation itself (AGM-R), nor is it a proxy statement (PSI) soliciting votes, but rather the outcome report.
2024-09-30 Japanese
内部統制報告書-第25期(2023/07/01-2024/06/30)
Governance Information Classification · 1% confidence The document is explicitly titled "内部統制報告書" (Internal Control Report) in the header and within the table structure. It references the legal basis as Article 24-4-4, Paragraph 1 of the Financial Instruments and Exchange Act (金融商品取引法第24条の4の4第1項), which mandates the filing of an Internal Control Report. The content discusses the framework, scope, criteria (using the standard from the Accounting Standards Board of Japan), and the conclusion that internal controls over financial reporting are effective as of the fiscal year-end (June 30, 2024). This directly corresponds to the definition of an Audit Report / Information (AR), which covers internal or regulatory stress tests and applied accounting principles, although 'Internal Control Report' is a specific type of assurance/audit-related filing. Given the provided codes, 'AR' (Audit Report / Information) is the closest fit for a formal report detailing internal control effectiveness assessment, distinct from a full annual report (10-K) or a simple earnings release (ER).
2024-09-27 Japanese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.